Bio-Techne (TECH) Cash from Operations Growth (3y) (2012 - 2026)
Powered by 
Analysis
Bio-Techne (TECH) Cash from Operations Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -0.27% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -7.35% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 16.85% |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 52.90% |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 96.08% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 6.22% |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 10.23% |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 4.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.59% |
| Mar 31, 2026 | 19.70% |
| Dec 31, 2025 | 8.58% |
| Sep 30, 2025 | -21.06% |
| Jun 30, 2025 | -1.49% |
| Mar 31, 2025 | -17.46% |
| Dec 31, 2024 | -5.83% |
| Sep 30, 2024 | 9.67% |
| Jun 30, 2024 | -14.79% |
| Mar 31, 2024 | 2.65% |
| Dec 31, 2023 | -2.35% |
| Sep 30, 2023 | -3.46% |
| Jun 30, 2023 | 23.02% |
| Mar 31, 2023 | 0.71% |
| Dec 31, 2022 | -2.94% |
| Sep 30, 2022 | 11.42% |
| Jun 30, 2022 | 22.45% |
| Mar 31, 2022 | 22.62% |
| Dec 31, 2021 | 29.44% |
| Sep 30, 2021 | 7.08% |